
Astraea
AI Operating System for Clinical Development
À propos
Description de l’entreprise en anglais
Astraea automates clinical trial biometrics from raw study inputs to FDA-ready outputs. The platform handles data normalization, CDISC mapping, SDTM, ADaM, TFLs, QC, and revision workflows in one auditable system, helping Phase II/III sponsors reduce months of manual programming and data management into automated, reviewable execution.
Thèmes
- Localisation
- San Francisco, CA, États-Unis
- Équipe
- 6 employés
- Promotion YC
- Spring 2026
- Statut
- Active
- Stade
- Phase d’amorçage





